-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
- Autolus Therapeutics plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$58.9M, a 32.8% decline year-over-year.
- Autolus Therapeutics plc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$194M, a 27.8% decline year-over-year.
- Autolus Therapeutics plc annual Operating Income (Loss) for 2023 was -$180M, a 25.3% decline from 2022.
- Autolus Therapeutics plc annual Operating Income (Loss) for 2022 was -$143M, a 1.67% decline from 2021.
- Autolus Therapeutics plc annual Operating Income (Loss) for 2021 was -$141M, a 16.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)